Edarbyclor — Cigna
Post-myocardial infarction with left ventricular failure/dysfunction
Preferred products
- candesartan
- candesartan/HCTZ
- eprosartan
- irbesartan
- irbesartan/HCTZ
- losartan
- losartan/HCTZ
- olmesartan
- olmesartan/amlodipine
- olmesartan/HCTZ
- olmesartan/amlodipine/HCTZ
- telmisartan
- telmisartan/amlodipine
- telmisartan/HCTZ
- valsartan
- valsartan/amlodipine
- valsartan/HCTZ
- valsartan/amlodipine/hydrochlorothiazide
Initial criteria
- If the patient has tried one Step 1 Product, approve a Step 2 Product.
- If the patient cannot swallow or has difficulty swallowing tablets, approve valsartan oral solution.
Approval duration
1 year